Discover how OS Therapies' immunotherapy, OST-HER2, originally developed for canine osteosarcoma, shows promising results in fast-tracking treatments for human osteosarcoma. Learn about comparative ...
Scientists at St. Jude Children’s Research Hospital identified chemokines expressed by osteosarcoma that improved CAR T-cell homing, with implications for immunotherapy development (MEMPHIS, Tenn. – ...
Osteosarcoma is a type of bone cancer. It can develop at any age, but most cases occur during childhood, early adolescence, and young adulthood. In young people, osteosarcoma tends to develop in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results